Pharmacokinetics and tissue distribution of cisplatin and conjugates of cisplatin with carboxyrmethyldextran and A5B7 monoclonal antibody in CD1 mice

Journal of Pharmaceutical Sciences

Volumn 86, Issue 12, 1997, Pages 1478-1483

  McIntosh, Deirdre P ^a,b   Cooke, Raymond J ^a,c   McLachlan, Andrew J ^a,d   Daley Yates, Peter T ^a,e   Rowland, Malcolm ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d University of Sydney   (Australia)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLDEXTRAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A5B7; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ANTINEOPLASTIC ACTIVITY; ARTICLE; DOSE TIME EFFECT RELATION; DRUG CONJUGATION; DRUG DISPOSITION; DRUG HALF LIFE; HUMAN; HUMAN CELL; HUMAN TISSUE; MEAN RESIDENCE TIME; STEADY STATE; TISSUE DISTRIBUTION; URINARY EXCRETION;

EID: 0031473148     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960282u     Document Type: Article

References (23)

1. Rosenberg, B.; van-Camp, L.; Trosko, J. F.; Mansour, V. H. Nature 1967, 222, 385-386.
2. Siddik, Z. H.; Newell, D. R.; Boxall, F. E.; and Harrap, K. R. Biochem. PharmacoL 1987, 36, 1925-1932.
3. King, F. G.; Dedrick, R. L. J. Pharmacokinet. Biopharm. 1991, 7, 95-99.
4. van-Hennick, M. B.; van-Vijgh, W. J. F.; Mein, I.; Elferink, F.; Vermorken, J. B.; Winograd, B.; Pinedo, H. M. Cancer Res. 1987, 47, 6297-6301.
5. Olsson, C.; Nygren, O.; Nilsson, M.; Sieving, B.; and Cavallin-Stahl, A Cancer Chemother Pharmacol 1995, 37, 23-31.
6. Harris, F. F.; Dedrick, R. L.; King, F. G. Toxicol. Lett. 1988, 43, 117-137.
7. Schechter, B.; Pauzner, R.; Arnon, R.; Haimovich, J.; Wilchek, M. Cancer Immunol. Immunother. 1987, 25, 225-230.
8. Koch, B.; Baum, W., Beck, E.; Eger, G.; Rohwer, P.; Kalden, Jr., J. R.; Gramatzki, M. Antibody, Immunoconjugates, Radiopharm. 1991, 4, 121-132.
9. Bolton, A. E.; Hunter, W. M. Biochem. J. 1973, 733, 529-538.
10. McIntosh, D. P.; Cooke, R. J.; Rowland, M.; Daley-Yates, P. T. Antibody, Immunoconjugates, Radiopharm. 1994, 7, 117-131.
11. Hurwitz, E.; Wilchek, M.; Pitha, J. J. Appl. Biochem. 1980, 2, 25-35.
12. Rowland, M.; Tozer, T. N. Clinical Pharmacokinetics, 3rd Ed.; Waverly: Philadephia, 1995.
13. Verotta, D.; Sheiner, L. B.; Ebling, W. F.; Stanski, D. R. J. Pharmacokinet. Biopharm. 1989, 17, 463-491.
14. Vaughan, D. P.; Dennis, M. J. Pharm. Sci. 1978, 67, 663-665.
15. Briand, C.; Bourdeaux, M.; Momburg. R. Eur. J. Drug Metab. Pharmacokinet. 1985, 10, 77-83.
16. Daley-Yates, P. T.; McBrian, D. C. H. Biochem. Pharmacol. 1982, 33, 3063-3070.
17. Melvik, J. E.; Domish, J. M.; Pettersen, E. O. Br. J. Cancer 1992, 66, 260-265.
18. Davies, B.; Morris, T. Pharm. Res. 1993, 10, 1093-1095.
19. Amon, R.; Schechter, B.; Wilchek, M. Immunobiology of Proteins and Peptides VI; Plenum: New York, 1991; pp 79-90.
20. Schechter, B.; Rosing, M. A.; Wilchek, M.; Arnon, R. Cancer Chemother. Pharmacol. 1989, 24, 161-166.
21. Rowland, M. Pharmacol. Ther. 1985, 29, 49-68.
22. Covcll, D. G.; Barbet, J.; Holton, O. D.; Black, C. D. V.; Parker, R. J.; Weinstein, J. N. Cancer Res. 1986, 46, 3969-3978.
23. Dobyan, D. C.; Leui, J.; Jacobs, C.; Kosek, J.; Weiner, M. W. Pharmacol. Exp. Ther. 1980, 213, 551-556.